Researcher.Life Logo

Archivos de prevención de riesgos laborales : Impact Factor & More

eISSN: 1578-2549pISSN: 1138-9672
JournalOpen Access

Key Metrics

CiteScore
0.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Archivos de prevención de riesgos laborales Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher Societat Catalana de Seguretat i Medicina del Treball (SCSMT)
Language Spanish,Catalan
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageSpanish,Catalan
Website URLVisit website
Publication Details
Publication Time 20
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyDulcinea
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Archivos de prevención de riesgos laborales ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Archivos de prevención de riesgos laborales

Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers
  • 1 Jun 2026
  • Lung Cancer
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Regional variations in molecular testing and treatment of patients with metastatic NSCLC in the Netherlands.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
DNA methylation biomarkers-based method for the differential diagnosis of multiple lung cancers.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers
  • 1 Jun 2026
  • Lung Cancer
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Regional variations in molecular testing and treatment of patients with metastatic NSCLC in the Netherlands.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
DNA methylation biomarkers-based method for the differential diagnosis of multiple lung cancers.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)
Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.
  • 1 Jun 2026
  • Lung cancer (Amsterdam, Netherlands)

FAQs on Archivos de prevención de riesgos laborales